Erminia Massarelli - Concepedia

Author

Erminia Massarelli

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

E Massarelli, E. Massarelli, Erminia Massarelli, Jonathan Goldman, Manisha H. Shah, Osaka, Patricia LoRusso

267

Publications

11.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center City of Hope City Of Hope National Medical Center Memorial Sloan Kettering Cancer Center University of Colorado Denver

About

Erminia Massarelli is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	4.3K
2	Immunology	12	14	1.2K
3	Health Sciences	9	9	2.6K
4	Cell Biology	6	6	412
5	Engineering	1	1	19

Erminia Massarelli

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network Version 3.2022Advanced Lung DiseaseMedicineCancer ManagementMetastatic Nsclc	2022	1.4K
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network	2021	990
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Journal of Clinical Oncology Neck CancerNeoadjuvant TherapyCancer ManagementImmunologyPathology	2017	641
Non–Small Cell Lung Cancer, Version 4.2024 Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Journal of the National Comprehensive Cancer Network Tumor BiologyActionable Molecular BiomarkersAdvanced Lung DiseaseVersion 4.2024Medicine	2024	614
<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang, Clinical Cancer Research	2007	598
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer Erminia Massarelli, William William, Faye M. Johnson, JAMA Oncology	2018	449
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network	2023	449
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells Chad Tang, James W. Welsh, Patricia M. de Groot, Clinical Cancer Research	2016	309
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation Adrian G. Sacher, Patricia LoRusso, Manish R. Patel, New England Journal of Medicine	2023	256
Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial Merrill S. Kies, Floyd Christopher Holsinger, J. Jack Lee, Journal of Clinical Oncology Induction PccOropharynx PrimariesNeoadjuvant TherapyMedicinePathology	2009	252

Page 1